Risk factors for breast cancer among women in Ekurhuleni Metropolitan Municipality, Gauteng province of South Africa, 2017‒2020: a case-control study.
Ekhuruleni Metropolitan Municipality
South Africa
age-standardised incidence rate
breast cancer
case-control study
incidence
odds ratio
risk factors
women
Journal
Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
06
2023
medline:
6
10
2023
pubmed:
6
10
2023
entrez:
6
10
2023
Statut:
epublish
Résumé
Breast cancer (BC) is the most common cancer among women in South Africa (SA), with an age-standardised incidence rate of 52.6 and an age-standardised mortality rate of 16.0 per 100,000 population. There is a paucity of evidence on the risk factors for BC among women of all races in SA. Given the rising prevalence of BC in SA, literature-based evidence is critical for the appropriate dissemination of preventative measures. This study aimed to identify the risk factors associated with the development of BC among women in Ekhuruleni Metropolitan Municipality. An unmatched case-control study was conducted from 1 January 2017 to 31 December 2020 using secondary data extracted from the Ekurhuleni Population-Based Cancer Registry. Unconditional multivariable logistic regression analysis was carried out using the adjusted odds ratio (aOR). The variables race, employment, human immunodeficiency virus (HIV), smoking and alcohol status were included in the multivariable logistic regression model while the model was adjusted for age. A total of 2,217 cases and 851 controls were enrolled in the study. The mean age (±SD) in years was 55.7 (±15.2). The White population group, being self-employed and being HIV positive was significantly associated with reduced odds of BC development. HIV-positive women were 61% less likely to have BC than women who were HIV-negative (aOR 0.39; 95% confidence interval (CI): 0.27‒0.57). White women were 65% less likely to have BC than women of other races (aOR 0.35; 95% CI: 0.29‒0.43). Self-employed women were 59% less likely to have BC than women who were formally employed (aOR 0.41; 95% CI: 0.18‒0.97). No evidence of association was observed between tobacco smoking and BC as well as alcohol consumption and BC. There was a 65% reduction in BC risk among White women compared to other races. HIV-positive women demonstrated a 61% lower likelihood of BC while self-employed women showed a 59% reduced risk of developing BC. These findings suggest that being White, self-employed or HIV-positive may provide some protection against BC. However, additional research is needed to validate these results and establish the underlying reasons behind these associations.
Identifiants
pubmed: 37799951
doi: 10.3332/ecancer.2023.1593
pii: can-17-1593
pmc: PMC10550293
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1593Informations de copyright
© the authors; licensee ecancermedicalscience.
Déclaration de conflit d'intérêts
No competing interests are declared by the authors.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Clin Oncol. 2001 Sep 15;19(18 Suppl):125S-127S
pubmed: 11560987
Br J Nutr. 2019 Mar;121(5):591-600
pubmed: 30704540
Radiologia. 2017 Sep - Oct;59(5):368-379
pubmed: 28712528
Int J Womens Health. 2021 Jan 18;13:101-110
pubmed: 33500666
Am J Epidemiol. 2005 Jan 15;161(2):121-35
pubmed: 15632262
Breast Cancer Res Treat. 2015 Nov;154(2):213-24
pubmed: 26546245
Int J Environ Res Public Health. 2020 Dec 20;17(24):
pubmed: 33419321
J Glob Oncol. 2016 Jul 27;2(5):302-310
pubmed: 28717716
Indian Pediatr. 2009 Oct;46(10):891-4
pubmed: 19430079
Breast Cancer Res Treat. 2013 Jul;140(1):177-86
pubmed: 23801159
Global Health. 2019 Jan 8;15(1):3
pubmed: 30621753
Breast Cancer Res Treat. 2014 Feb;144(1):1-10
pubmed: 24477977
BMC Womens Health. 2017 Mar 6;17(1):14
pubmed: 28264686
Pharm Res. 2008 Sep;25(9):2097-116
pubmed: 18626751
Ecancermedicalscience. 2021 Mar 25;15:1214
pubmed: 33912239
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Ugeskr Laeger. 2021 Apr 5;183(14):
pubmed: 33832554
Int J Cancer. 2023 Jan 15;152(2):183-194
pubmed: 36054877
J Hum Lact. 1989 Mar;5(1):1-2
pubmed: 2730764
Int J Environ Res Public Health. 2022 Jul 01;19(13):
pubmed: 35805784
Cancer. 2016 Jul 15;122(14):2138-49
pubmed: 26930024
J Natl Cancer Inst. 2018 Sep 1;110(9):959-966
pubmed: 29529223
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1557-68
pubmed: 20507845
Lancet Oncol. 2015 Aug;16(8):e414-21
pubmed: 26248849
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1158-1164
pubmed: 30779085
BMC Public Health. 2022 Feb 25;22(1):395
pubmed: 35216565
Cancer Epidemiol. 2020 Apr;65:101701
pubmed: 32169796
Alcohol Res. 2020 Jun 18;40(2):11
pubmed: 32582503
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Cancer Causes Control. 2021 Apr;32(4):415-422
pubmed: 33471235
Breastfeed Med. 2015 May;10(4):186-96
pubmed: 25831234
Policy Polit Nurs Pract. 2021 Feb;22(1):28-40
pubmed: 33076774
S Afr Med J. 2015 Jan 12;105(2):107-9
pubmed: 26242527